English
Home > Products > 2-methylisoquinolinium benzenesulfonate

China 2-methylisoquinolinium benzenesulfonate Factory

To frequently enhance the administration program by virtue on the rule of "sincerely, very good faith and high-quality are the base of enterprise development", we widely absorb the essence of related products internationally, and consistently develop new products to fulfill the calls for of customers for 2-methylisoquinolinium benzenesulfonate,CAS NO 1075727-00-2,1075727-00-2,Atracurium besylate intermediate,Atracurium besylate advance intermediate, With our rules of " organization track record, partner trust and mutual benefit", welcome all of you to function together , improve jointly.
2-methylisoquinolinium benzenesulfonate, Welcome to visit our company and factory, there are various items displayed in our showroom that will meet your expectation, meanwhile, if you are convenient to visit our website, our sales staff will try their efforts to supply you the best service

Related Products

Hot Products

  • Lubiprostone

    Lubiprostone

    Product Name:Lubiprostone
    Molecular Formula:C20H32F2O5
    Molecular Weight:390.47
    CAS Registry Number:136790-76-6
  • Methyl 2-(2,3-dichlorobenzylidine)acetoacetate

    Methyl 2-(2,3-dichlorobenzylidine)acetoacetate

    Product Name:Methyl 2-(2,3-dichlorobenzylidine)acetoacetate
    Molecular Formula:C12H10Cl2O3
    Molecular Weight:273.11
    CAS Registry Number:74073-22-6
  • Omarigliptin (MK-3102)

    Omarigliptin (MK-3102)

    Product Name:Omarigliptin (MK-3102)
    Molecular Formula:C17H20F2N4O3S
    Molecular Weight;398.43
    CAS Registry Number;1226781-44-7
  • 5`-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2`,3`-diacetate

    5`-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2`,3`-diacetate

    Product Name:5`-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2`,3`-diacetate
    Molecular Formula:C19H26FN3O8
    Molecular Weight:443.42
    CAS Registry Number:162204-20-8
  • 2-Bromopropane

    2-Bromopropane

    Product Name:2-Bromopropane
    Molecular Formula:C3H7Br
    Molecular Weight:122.99
    CAS Registry Number:75-26-3
  • Trityl candesartan

    Trityl candesartan

    Product Name:Trityl candesartan
    Molecular Formula:C43H34N6O3
    Molecular Weight:682.77
    CAS Registry Number:139481-72-4
  • Related Blog
  • Reviews

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept